New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine

Neuropsychopharmacology

Volumn 19, Issue 3, 1998, Pages 194-199

  Bowden, Charles L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bipolar disorder; Lamotrigine; Manic depressive; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID;

BIPOLAR DEPRESSION; DRUG EFFICACY; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SIGNAL TRANSDUCTION; SPECTRUM; SYMPTOMATOLOGY;

EID: 0032171603     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00025-6     Document Type: Article

References (41)

1. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., Morris D.D. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA. 271:1994;918-924.
2. Bowden C.L. Predictors of response to divalproex and lithium. J Clin Psychiat. 56:1995;25-30.
3. Bowden C.L., Calabrese J.R., Wallin B.A., Swann A.C., McElroy S.L., Risch S.C., Hirschfeld R.M.A. Who enters therapeutic trials? Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol Bull. 31:1995;103-109.
4. Bowden C.L. Treatment of bipolar disorder. Current Review of Mood & Anxiety Disorders. 1:1997;167-176.
5. Bowden C.L., Janicak P.G., Orsulak P., Swann A.C., Davis J.M., Calabrese J.R., Goodnick P., Small J.G., Rush A.J., Kimmel S.E., Risch S.C., Morris D.D. Relation of serum valproate concentration to response in mania. Am J Psychiat. 153:1996;765-770.
6. Bowden C.L. Toward an integrated biological model of bipolar disorder. Joffe R., Young L.T. Bipolar Disorder. Biological Models and Their Clinical Applications:1997;235-254 Marcel Dekker Inc, New York.
7. Brady K.T., Sonne S.C. The relationship between substance abuse and bipolar disorder. J Clin Psychiat. 56:1995;19-24.
8. Calabrese JR, Woyshville MJ, Bowden CL, Rhodes L, McElroy S, Keck P, Cookson J, Kundu S, Andersen J, Ascher J, Bolden-Watson C, Paterson G (1995): "Spectrum of efficacy" of lamotrigine in treatment - refractory manic depression. Paper presented at the 2nd international conference on new directions in affective disorders in Jerusalem.
9. Calabrese J.R., Delucchi G.A. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiat. 147:1990;431-434.
10. Denicoff K.D., Smith-Jackson E., Disney E., Syed A.O., Leverich G.S., Post R.M. Carbamazepine, lithium, and the combination. A bipolar maintenance trial:1995;178, Proc Am Psychiat Ass.
11. Evans D.A., Nemeroff C.B. The dexamethasone suppression test in mixed bipolar disorder. Am J Psychiat. 140:1983;615-617.
12. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., Lavelle J. Comparison of standard and low-serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 321:1989;1489-1493.
13. Gitlin M.J., Cochran S.D., Jamison K.R. Maintenance lithium treatment. Side effects and compliance J Clin Psychiatr. 50:1989;127-131.
14. Goa K.L., Ross S.R., Chrisp P. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy Drugs. 46:1993;152-176.
15. Goldberg J.F., Harrow M., Grossman L.S. Course and outcome in bipolar affective disorder. Am J Psychiat. 152:1995;379-384.
16. Grof P., Alda M., Grof E., Fox D., Cameron P. The challenge of predicting response to stabilizing lithium treatment. The importance of patient selection. Br J Psychiat. 163(S):1993;16-19.
17. Grunze H., Wegerer J.V., Walden J. Lamotrigine may limit pathological excitation by modulating calcium and potassium currents. Eur Neuropsychopharmacol. 6:1966;S4-S155.
18. Harrow M., Goldberg J.F., Grossman L.S., Meltzer H.Y. Outcome in manic disorders. A naturalistic follow-up study Arch Gen Psychiat. 47:1990;665-671.
19. Himmelhoch J.M., Garfinkel M.E. Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 22:1986;613-620.
20. Janicak P.G., Sharma R.P., Easton M., Comaty J.E., Davis J.M. A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacol Bull. 25:1989;243-245.
21. Janicak P.G., Davis J.M., Preskorn S.H., Ayd T.J. Principles and Practice of Psychopharmacotherapy. 1993;Williams & Wilkins, Baltimore. a pp 351-353.
22. Janicak PG, Sharma R, Peterson J, Leach A, Davis JM (1993b): A double-blind, placebo-controlled trial of verapamil for acute mania: Preliminary results. ACNP Abstracts of Panels and Posters 245 (abstract).
23. Krishnan R.R., Maltbie A.A., Davidson J.R. Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. Am J Psychiat. 140:1983;203-205.
24. Lambert P.A., Cavaz G., Borselli S., Carrel S. Action neuropsychotrope d'un nouvel anti-épileplique. Le Dépamide Ann Med Psychol. 1:1966;707-710.
25. Lambert P.A., Venaud G. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders. Nervure, Journal de Psychiatrie. 7:1995;1-9.
26. Lenox R.H., Watson D.B., Patel J., Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570:1992;333-340.
27. Lerer B., Moore N., Meyendorff E., Cho S.R., Gershon S. Carbamazepine versus lithium in mania. A double-blind study J Clin Psychiat. 48:1987;89-93.
28. Maj M., Priozzi R., Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology. 98:1989;535-538.
29. Manji H.K., Potter W.Z. Monoaminergic systems. Joffe R., Young L.T. Bipolar Disorder. Biological Models and their Clinical Application:1997;1-40 Marcel Dekker Inc, New York.
30. McFarland B.H., Miller M.R., Straumfjord A.A. Valproate use in the older manic patient. J Clin Psychiat. 51:1990;479-481.
31. Okuma T., Yamashita I., Takahashi R., Itoh H., Otsuki S., Wantanabe S., Sarai K., Hazama H., Inanaga K. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopysychiatry. 23:1990;143-150.
32. Papatheodorou G., Kutcher S.P. Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol Bull. 29:1993;213-219.
33. Petty F., Rush A.J., Davis J.M., Calabrese J.R., Small J.G., Swann A.E., Kramer G.L., Orsulak P.J., Blake M., Bowden C.L. Plasma GABA predicts response to divalproex in mania. Biolog Psychiat. 37:1995;593-683.
34. Pope H.G. Jr., McElroy S.L., Keck P.E. Jr., Hudson J.I. Valproate in the treatment of acute mania. A placebo-controlled study Arch Gen Psychiat. 48:1991;62-68.
35. Post R.M., Uhde T.W., Ballenger J.C. The efficacy of carbamazepine in affective illness. Adv Biochem Psychopharmacol. 39:1984;421-437.
36. Prien R.F., Himmelhoch J.M., Kupfer D.J. Treatment of mixed mania. J Aff Dis. 15:1988;9-15.
37. Secunda S., Katz M.M., Swann A., Koslow S.H., Maas J.W., Chuang S., Croughan J. Mania. Diagnosis, state measurement, and prediction of treatment response J Aff Dis. 8:1985;113-121.
38. Shaw E.D., Mann J.J., Stokes P.E., Manevitz A.Z. Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients. Am J Psychiat. 143:1986;1166-1169.
39. Small J.G., Klapper M.H., Milstein V., Kellams J.J., Miller M.J., Marhenke J.D., Small I.F. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiat. 48:1991;915-921.
40. Swann A.C., Secunda S.K., Katz M.M., Koslow S.H., Maas J.W., Chang S., Robins E. Lithium treatment of mania. Clinical characteristics, specificity of symptom change, and outcome Psychiat Res. 18:1986;127-141.
41. Tohen M., Watemaux C.M., Tsuang M.T., Hunt A.T. Four-year follow-up of twenty-four first-episode manic patients. J Aff Dis. 19:1990;76-86.